What are the recommended treatment options for vaginitis, including first‑line therapy for bacterial vaginosis, Candida infection, and Trichomonas, and special considerations in pregnancy?

Treatment of Vaginitis

Overview of First-Line Therapy by Etiology

For bacterial vaginosis, use oral metronidazole 500 mg twice daily for 7 days; for vulvovaginal candidiasis, use topical azoles or oral fluconazole; and for trichomoniasis, use metronidazole 2 g orally as a single dose. 1

---

Bacterial Vaginosis (BV)

First-Line Treatment (Non-Pregnant Women)

The CDC recommends three equivalent first-line options: 1

• Metronidazole 500 mg orally twice daily for 7 days (achieves ~95% cure rate) 1
• Metronidazole 0.75% vaginal gel once daily for 5 days (comparable efficacy to oral) 1
• Clindamycin 2% cream intravaginally at bedtime for 7 days (somewhat less effective than metronidazole regimens) 1

Alternative Regimen (Lower Efficacy)

• Metronidazole 2 g orally as a single dose yields only ~84% cure rate versus ~95% for the 7-day regimen and should NOT be used as first-line therapy 1, 2

Critical Patient Counseling

• Patients MUST abstain from alcohol during metronidazole therapy and for 24 hours after the last dose to avoid disulfiram-like reactions (flushing, nausea, vomiting, headache) 1
• Clindamycin cream and ovules are oil-based and can weaken latex condoms and diaphragms, potentially reducing contraceptive effectiveness 1

Metronidazole Allergy or Intolerance

• Oral clindamycin 300 mg twice daily for 7 days is the preferred alternative 1, 2
• Metronidazole vaginal gel may be used for patients unable to tolerate systemic metronidazole 1
• Patients allergic to oral metronidazole should NEVER receive vaginal metronidazole formulations 1, 2

Follow-Up

• Routine follow-up visits are unnecessary if symptoms resolve 1, 2
• Recurrence is common (50-80% within one year); instruct patients to return only if symptoms recur 1, 3

Partner Treatment

• Routine treatment of sexual partners is NOT recommended, as clinical trials showed partner therapy does not improve therapeutic response or reduce recurrence 1, 2

---

Bacterial Vaginosis in Pregnancy

General Principles

All symptomatic pregnant women should be treated because BV is associated with preterm rupture of membranes, preterm labor, preterm birth, chorioamnionitis, postpartum endometritis, and post-cesarean wound infection. 1, 2

High-Risk Pregnant Women (Prior Preterm Delivery)

Screen and treat asymptomatic BV in the earliest part of the second trimester: 2

• Recommended: Metronidazole 250 mg orally three times daily for 7 days 2
• Alternatives: Metronidazole 2 g orally single dose OR clindamycin 300 mg orally twice daily for 7 days 2

Low-Risk Pregnant Women (No Prior Preterm Delivery)

Treat symptomatic BV to relieve symptoms: 2

• Recommended: Metronidazole 250 mg orally three times daily for 7 days 2
• Alternatives: Metronidazole 2 g orally single dose; clindamycin 300 mg orally twice daily for 7 days; OR metronidazole 0.75% gel intravaginally twice daily for 5 days 2
• Some experts prefer systemic therapy to treat possible subclinical upper genital tract infections 2

Critical Pregnancy Considerations

• Lower doses of metronidazole are recommended in pregnancy to minimize fetal exposure 2
• DO NOT use clindamycin vaginal cream during pregnancy—two randomized trials showed increased preterm deliveries and neonatal infections 1, 2
• Multiple studies and meta-analyses have found no consistent teratogenic or mutagenic risk with metronidazole use in pregnancy 1
• Data are limited for metronidazole vaginal gel during pregnancy 2

---

Vulvovaginal Candidiasis (VVC)

First-Line Treatment (Non-Pregnant Women)

Topical azoles and oral fluconazole are equally effective for uncomplicated VVC: 4, 5

• Topical azoles (clotrimazole, miconazole, terconazole)—various formulations and durations (1-7 days) 4, 6
• Oral fluconazole 150 mg as a single dose 4, 6

Complicated VVC (Recurrent or Severe)

Recurrent VVC is defined as 4 or more episodes per year: 5

• Initial treatment: Extended duration with topical azole (7-14 days) OR two doses of fluconazole 150 mg given 72 hours apart 4, 5
• Maintenance therapy: Weekly oral fluconazole for up to 6 months enhances treatment success 5, 4

Non-Albicans Candida Species

• Azole therapy is unreliable for C. glabrata, C. krusei, and other non-albicans species 4
• Topical boric acid or topical flucytosine frequently effective for these resistant species 4, 7

VVC in Pregnancy

Only topical azoles are recommended during pregnancy—oral fluconazole should be avoided 6, 5

---

Trichomoniasis

First-Line Treatment (Non-Pregnant Women)

Metronidazole 2 g orally as a single dose is the recommended regimen: 2

• Achieves 90-95% cure rates 2
• Alternative: Metronidazole 500 mg orally twice daily for 7 days (equal efficacy) 2

Treatment Failure

• If initial treatment fails: Re-treat with metronidazole 500 mg twice daily for 7 days 2
• If repeated failure occurs: Metronidazole 2 g orally once daily for 3-5 days 2
• For culture-documented infection unresponsive to standard regimens: Consult an expert and consider susceptibility testing 8, 2

Partner Treatment

Sex partners MUST be treated concurrently 8, 2

• Patients should avoid sexual intercourse until both patient and partner(s) complete therapy and are asymptomatic 8, 2
• Partner treatment enhances cure rates 2, 5

Trichomoniasis in Pregnancy

Pregnant women should be treated with metronidazole 2 g orally as a single dose after the first trimester 8

• Treatment is warranted for prevention of preterm birth 5
• Historical note: 1993 CDC guidelines contraindicated metronidazole in the first trimester; this restriction was lifted in later updates based on safety evidence 1

Follow-Up

• Test of cure is NOT recommended for asymptomatic patients after treatment 5, 8

---

Key Clinical Pitfalls to Avoid

Bacterial Vaginosis

• DO NOT use single-dose metronidazole 2 g as first-line therapy—it has inferior efficacy (84% vs 95%) 1
• NEVER prescribe vaginal metronidazole to patients with oral metronidazole allergy 1, 2
• AVOID clindamycin cream during pregnancy—associated with adverse neonatal outcomes 1, 2
• Always counsel complete alcohol abstinence during and 24 hours after metronidazole 1

Vulvovaginal Candidiasis

• Only use topical azoles during pregnancy—avoid oral fluconazole 6, 5
• Consider non-albicans species in treatment-refractory cases—culture may be needed 4, 6

Trichomoniasis

• Always treat sexual partners concurrently—this is the only STI where treatment recommendations vary by sex 7, 8
• Metronidazole gel is NOT effective for trichomoniasis—only oral preparations achieve therapeutic levels 2

---

Special Populations

HIV-Infected Patients

Patients with HIV and BV or trichomoniasis should receive the same treatment regimens as HIV-negative patients 2

Pre-Procedural Prophylaxis

Administering metronidazole for BV markedly reduces post-abortion pelvic inflammatory disease 1

Refractory Cases

When standard therapy fails after extended treatment and partner therapy, refer to an infectious disease specialist or experienced gynecologist for susceptibility testing and alternative regimens 1, 7